Noevir Holdings Co., Ltd.

4928

JP3760450001

Personal Products

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-01 am EDT			5-day change	1st Jan Change
5,250 ^JPY	+0.57%		+1.35%	+2.14%

2023	Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending September 30, 2024	CI
2023	Noevir Holdings Co., Ltd. Announces Dividend for the Fiscal Year Ended September 30, 2023, Payable on December 11, 2023	CI

Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 2022

May 11, 2022 at 02:00 am EDT

Noevir Holdings Co., Ltd. provided dividend guidance of JPY 210 per share for the year ending September 2022.

Latest news about Noevir Holdings Co., Ltd.

Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending September 30, 2024	Nov. 07	CI
Noevir Holdings Co., Ltd. Announces Dividend for the Fiscal Year Ended September 30, 2023, Payable on December 11, 2023	Nov. 07	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2024	Nov. 07	CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending September 30, 2023	23-08-07	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2024	23-08-07	CI
Noevir Holdings Co., Ltd. Reports Earnings Results for the Half Year Ended March 31, 2023	23-05-10	CI
Noevir Holdings Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending September 30, 2023	23-05-10	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending September 30, 2023	23-05-10	CI
Noevir Holdings Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending September 30, 2023	23-02-07	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending March 2023 and for the Fiscal Year Ending September 30, 2023	23-02-07	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Six Months Ending March 2023 and for the Fiscal Year Ending September 30, 2023	22-11-10	CI
Noevir Holdings Co., Ltd. Provides Year-End Dividend Guidance for the Fiscal Year Ending September 30, 2023	22-11-10	CI
Noevir Holdings Co., Ltd. Announces Year-End Dividend for the Fiscal Year Ended September 30, 2022, Payable on December 09, 2022	22-11-10	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending September 2022	22-08-04	CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 30, 2022	22-08-04	CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 2022	22-05-11	CI
Noevir Holdings Co., Ltd. Provides Consolidated Earnings Guidance for the Period Ending September 2022	22-05-11	CI
Noevir Holdings Co., Ltd. Provides Earnings Guidance for the Six Months Ending March 2022 and for the Year Ending September 2022	22-02-08	CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 2022	22-02-08	CI
FACTBOX-Japanese companies opening COVID-19 vaccination sites amid slow national rollout	21-06-04	RE
An unknown buyer acquired a 12.9% stake in Noevir Holdings Co., Ltd. from Takashi Okura.	20-08-02	CI
Noevir Holdings Co., Ltd. Announces Distribution	19-11-18	CI
Noevir Holdings Co., Ltd. Provides Dividend Guidance for the Year Ending September 30, 2019	19-08-13	CI
Noevir Holdings Co., Ltd. Announces Consolidated Earnings Results for the Nine Months Ended June 30, 2019; Provides Earnings Guidance for the Fiscal Year Ending September 30, 2019	19-08-13	CI
Noevir Holdings Co., Ltd. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended December 31, 2018; Provides Earnings Forecast for the Half Year of the Fiscal Year Ending Sept. 30, 2019; Provides Earnings Forecast for the Full Year of the Fiscal Year Ending Sept. 30, 2019; Provides Dividend Forecast for the Fourth Quarter of Fiscal Year Ending Sept. 30, 2019	19-02-11	CI

Chart Noevir Holdings Co., Ltd.

Duration

Period

More charts

Noevir Holdings Co., Ltd. is a Japan-based company engaged in the manufacture and sale of cosmetics, toiletries, pharmaceuticals and foods, as well as the purchase and sale of cosmetic products. The Company operates in three business segments. The Cosmetics segment is engaged in the manufacture and sale of cosmetics and toiletries, as well as the purchase and sale of cosmetic products. The Pharmaceuticals and Foods segment is engaged in the manufacture and sale of general drugs and foods. The Others segment is engaged in the purchase and sale of apparels, body fashion, aircrafts and vessels, as well as air transportation business.

Sector

Personal Products

Calendar

2024-05-08 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Noevir Holdings Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

5,220 JPY

Average target price

5,730 JPY

Spread / Average Target

+9.77%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Cosmetics & Perfumes

	1st Jan change	Capi.
NOEVIR HOLDINGS CO., LTD.	+2.14%	1.13B
L'ORÉAL	-2.44%	251B
KAO CORPORATION	+13.66%	19.26B
GALDERMA GROUP AG	-.--%	17.78B
SHISEIDO COMPANY, LIMITED	+2.40%	10.7B
COTY INC.	-7.89%	10.24B
AMOREPACIFIC CORPORATION	+16.90%	7.51B
PROYA COSMETICS CO.,LTD.	+10.15%	5.97B
NATURA &CO HOLDING S.A.	-1.78%	4.43B
INTER PARFUMS, INC.	-19.19%	3.73B

Cosmetics & Perfumes